Trial Profile

A Pilot Study in Humans to Evaluate the Intranasal Delivery of Epinephrine

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 15 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Epinephrine (Primary) ; Epinephrine
Indications Anaphylaxis
Focus Adverse reactions; Pharmacokinetics; Registrational
Sponsors Bryn Pharma

Most Recent Events

12 Dec 2023 According to a Bryn Pharma media release, data from this study were published by the Journal of Allergy and Clinical Immunology (JACI): Global.
12 Dec 2023 Results presented in a Bryn Pharma media release.
04 Jan 2021 According to a Bryn Pharma media release, results from this study have been accepted for presentation at the 2021 American Academy of Asthma, Allergy and Immunology (AAAAI) annual meeting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com